Publication date: 10 January 2027 Source: European Journal of Pharmacology, Volume 1040 Author(s): Jia Deng, Yan Liu, Na Chen, Yuhan Zhang, Hui Guo, Jin Zhu, Feng Wang
Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis. // Biophysical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S0014299926010113?dgcid=rss_sd_all
Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis. Biophysical Reports. https://www.sciencedirect.com/science/article/pii/S0014299926010113?dgcid=rss_sd_all
“Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis.” Biophysical Reports.
@article{article11140,
title = {Design of a Kv1.3×CD25 bispecific antibody to preferentially inhibit activated T cells and ameliorate T-cell-driven colitis},
journal = {Biophysical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S0014299926010113?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...